For: | Skrzydlewska E, Sulkowska M, Wincewicz A, Koda M, Sulkowski S. Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J Gastroenterol 2005; 11(27): 4225-4229 [PMID: 16015694 DOI: 10.3748/wjg.v11.i27.4225] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i27/4225.htm |
Number | Citing Articles |
1 |
Suelem D. Ramalho, Lorena R. F. de Sousa, Marcela C. M. Burger, Maria Inês S. Lima, M. Fátima das G. F. da Silva, João B. Fernandes, Paulo C. Vieira. Evaluation of flavonols and derivatives as human cathepsin B inhibitor. Natural Product Research 2015; 29(23): 2212 doi: 10.1080/14786419.2014.1002404
|
2 |
Yasuhiro Tsume, Gordon L. Amidon. The Feasibility of Enzyme Targeted Activation for Amino Acid/Dipeptide Monoester Prodrugs of Floxuridine; Cathepsin D as a Potential Targeted Enzyme. Molecules 2012; 17(4): 3672 doi: 10.3390/molecules17043672
|
3 |
Justyna Szumilo, Franciszek Burdan, Krzysztof Zinkiewicz, Jaroslaw Dudka, Robert Klepacz, Andrzej Dabrowski, Elzbieta Korobowicz. Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma.. Folia Histochemica et Cytobiologica 2010; 47(4) doi: 10.2478/v10042-008-0012-8
|
4 |
Tadeusz Sebzda, Jan Gnus, Barbara Dziadkowiec, Miroslaw Latka, Jakub Gburek. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma. World Journal of Gastroenterology 2021; 27(39): 6673-6688 doi: 10.3748/wjg.v27.i39.6673
|
5 |
Chih-Ching Wu, Chia-Wei Hsu, Chi-De Chen, Chia-Jung Yu, Kai-Ping Chang, Dar-In Tai, Hao-Ping Liu, Wen-Hui Su, Yu-Sun Chang, Jau-Song Yu. Candidate Serological Biomarkers for Cancer Identified from the Secretomes of 23 Cancer Cell Lines and the Human Protein Atlas. Molecular & Cellular Proteomics 2010; 9(6): 1100 doi: 10.1074/mcp.M900398-MCP200
|
6 |
Wan-Nan Chen, Jin-Yan Chen, Bo-Yan Jiao, Wan-Song Lin, Yun-Li Wu, Ling-Ling Liu, Xu Lin. Interaction of the Hepatitis B Spliced Protein with Cathepsin B Promotes Hepatoma Cell Migration and Invasion. Journal of Virology 2012; 86(24): 13533 doi: 10.1128/JVI.02095-12
|
7 |
Tadeusz Sebzda, Jakub Karwacki, Anna Cichoń, Katarzyna Modrzejewska, Jerzy Heimrath, Mirosław Łątka, Jan Gnus, Jakub Gburek. Association of Serum Proteases and Acute Phase Factors Levels with Survival Outcomes in Patients with Colorectal Cancer. Cancers 2024; 16(13): 2471 doi: 10.3390/cancers16132471
|
8 |
Doerthe Kuester, Hans Lippert, Albert Roessner, Sabine Krueger. The cathepsin family and their role in colorectal cancer. Pathology - Research and Practice 2008; 204(7): 491 doi: 10.1016/j.prp.2008.04.010
|
9 |
Ziqi Zhang, Pengfei Yue, Tianqi Lu, Yang Wang, Yuquan Wei, Xiawei Wei. Role of lysosomes in physiological activities, diseases, and therapy. Journal of Hematology & Oncology 2021; 14(1) doi: 10.1186/s13045-021-01087-1
|
10 |
Geum-A Lee, Kyung-Chul Choi, Kyung-A Hwang. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells. Environmental Toxicology and Pharmacology 2017; 49: 48 doi: 10.1016/j.etap.2016.11.016
|
11 |
Yolanda M. Fortenberry, Stephanie Brandal, Ryan C. Bialas, Frank C. Church. Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migration. Biochimica et Biophysica Acta (BBA) - General Subjects 2010; 1800(6): 580 doi: 10.1016/j.bbagen.2010.03.003
|
12 |
Enas A. Hamed, Madeha M. Zakary, Reffat M. Abdelal, Effat M. Abdel Moneim. Vasculopathy in type 2 diabetes mellitus: role of specific angiogenic modulators. Journal of Physiology and Biochemistry 2011; 67(3): 339 doi: 10.1007/s13105-011-0080-8
|
13 |
Mariola Sulkowska, Waldemar Famulski, Andrzej Wincewicz, Tadeusz Moniuszko, Bogusłtaw Kȩdra, Mariusz Koda, Bogdan Zalewski, Marek Baltaziak, Stanislaw Sulkowski. Levels of Ve-Cadherin Increase Independently of Vegf in Preoperative Sera of Patients with Colorectal Cancer. Tumori Journal 2006; 92(1): 67 doi: 10.1177/030089160609200111
|
14 |
Kathryn M. Bell, Steven E. Kornguth. Handbook of Biosensors and Biochips. 2007; doi: 10.1002/9780470061565.hbb139
|
15 |
Jean Breton, Matthew C. Gage, Alastair W. Hay, Jeffrey N. Keen, Christopher P. Wild, Clare Donnellan, John B. C. Findlay, Laura J. Hardie. Proteomic Screening of a Cell Line Model of Esophageal Carcinogenesis Identifies Cathepsin D and Aldo-Keto Reductase 1C2 and 1B10 Dysregulation in Barrett’s Esophagus and Esophageal Adenocarcinoma. Journal of Proteome Research 2008; 7(5): 1953 doi: 10.1021/pr7007835
|